Related Experiment Video
Updated: Aug 16, 2026
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Effectiveness of multitarget stool DNA versus faecal immunochemical testing alone in detecting colorectal cancer and
Jerrald Lau1, Jolin Lim2, Megan Lee2
1Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Level 8, NUHS Tower Block, 119228 Singapore; Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, #10-01, 117549 Singapore.
Background:
Colorectal cancer screening (CRC) permits early detection of colorectal neoplasms. While faecal immunochemical test (FIT) is commonly used, multitarget stool DNA (mt-sDNA) has emerged as a promising alternative due to FIT's low sensitivity for advanced adenomas but has yet to be widely adopted. The objective of this review was to summarise the findings of studies comparing characteristics of mt-sDNA versus FIT in samples which completed both tests.
Methods:
A comprehensive search was conducted across three electronic databases (PubMed, CINAHL and Scopus) from inception to 30 November 2025. The search covered keywords including "Colorectal Neoplasms", "Diagnosis", "Faeces", "Immunochemical", "Occult blood", "DNA", "Research Design" and associated MeSH terms.
Results:
Six studies fulfilled inclusion criteria out of an initial 2629 unique records. mt-sDNA demonstrated superior sensitivity compared to FIT in detecting CRC (100.0% - 43.0%) and advanced adenomas (53.3% - 27.2%) but lower specificity (92.0% - 86.6%). Five studies provided receiver operating characteristic curves and the corresponding area under curve statistics, with mt-sDNA outperforming FIT especially when advanced adenoma detection was included. mt-sDNA was positively associated with size and quantity of tumours detected, outperforming standard FIT in number needed to screen as well as positive and negative predictive value metrics.
Conclusions:
mt-sDNA shows promising test characteristics, but poorer comparative specificity may have downstream implications for population health screening. The economic, logistical and psychological impact of false positives must be considered. Current screening uptake and efforts to improve compliance should be considered before substituting FIT with mt-sDNA on account of higher per-unit cost.
More Related Videos
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
04:57Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples
Published on: April 25, 2025
Related Concept Videos
01:30Serum Laboratory Studies, Stool Test, Breath Test
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...